Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Commentary on "the Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics".

× No keyword cloud information.

16 in total

1. Is there a characteristic lipid profile in Alzheimer's disease?

Authors: Marwan Sabbagh; H Reza Zahiri; Joanne Ceimo; Kimbal Cooper; William Gaul; Donald Connor; D Larry Sparks
Journal: J Alzheimers Dis Date: 2004-12 Impact factor: 4.472

2. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

Authors: D Larry Sparks; Marwan N Sabbagh; Donald J Connor; Jean Lopez; Lenore J Launer; Patrick Browne; Dawn Wasser; Sherry Johnson-Traver; Jeff Lochhead; Chuck Ziolwolski
Journal: Arch Neurol Date: 2005-05

3. Statin use and the risk of incident dementia: the Cardiovascular Health Study.

Authors: Thomas D Rea; John C Breitner; Bruce M Psaty; Annette L Fitzpatrick; Oscar L Lopez; Anne B Newman; William R Hazzard; Peter P Zandi; Gregory L Burke; Constantine G Lyketsos; Charles Bernick; Lewis H Kuller
Journal: Arch Neurol Date: 2005-07

4. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

Authors: Kenneth Rockwood; Susan Kirkland; David B Hogan; Chris MacKnight; Heather Merry; René Verreault; Christina Wolfson; Ian McDowell
Journal: Arch Neurol Date: 2002-02

5. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.

Authors: C Dufouil; F Richard; N Fiévet; J F Dartigues; K Ritchie; C Tzourio; P Amouyel; A Alpérovitch
Journal: Neurology Date: 2005-05-10 Impact factor: 9.910

6. Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.

Authors: G Li; R Higdon; W A Kukull; E Peskind; K Van Valen Moore; D Tsuang; G van Belle; W McCormick; J D Bowen; L Teri; G D Schellenberg; E B Larson
Journal: Neurology Date: 2004-11-09 Impact factor: 9.910

7. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

Authors: B Wolozin; W Kellman; P Ruosseau; G G Celesia; G Siegel
Journal: Arch Neurol Date: 2000-10

8. Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial.

Authors: D L Sparks; D J Connor; M N Sabbagh; R B Petersen; J Lopez; P Browne
Journal: Acta Neurol Scand Suppl Date: 2006

9. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

Authors: Peter P Zandi; D Larry Sparks; Ara S Khachaturian; Joann Tschanz; Maria Norton; Martin Steinberg; Kathleen A Welsh-Bohmer; John C S Breitner
Journal: Arch Gen Psychiatry Date: 2005-02

Review 10. Statins in the prevention and treatment of Alzheimer disease.

Authors: Milita Crisby; Lars A Carlson; Bengt Winblad
Journal: Alzheimer Dis Assoc Disord Date: 2002 Jul-Sep Impact factor: 2.703